Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Licenses Gene Modification Technology to Ingenium Pharmaceuticals

NEW YORK, Jan. 21 - Incyte Genomics licensed animal genetic modification patents to Ingenium Pharmaceuticals, the companies said today.


Financial details of the agreement were not disclosed.


Ingenium Pharmaceuticals, based in Munich, said the license will enable the company to bring its technology producing murine models with gene alterations to the USmarket.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.